US monthly menopause hormone prescriptions rise from 2 million to 4.9 million


Researchers estimated that monthly dispensing rose from 28 to 67 prescriptions per 1,000 women aged 40–74, as increases that began in 2024 continued into 2026.
Monthly US dispensing of menopause hormone therapy to women aged 40–74 rose from 2 million prescriptions in 2023 to 4.9 million over the period studied, researchers reported 19 November in JAMA. The increase began in 2024 and continued into 2026.
Many women and doctors had turned away from hormone therapy in the early 2000s after the Women’s Health Initiative raised safety concerns. Later research has given a more nuanced picture of the benefits and risks at different ages.
Using population data, the researchers estimated that the monthly dispensing rate rose from 28 to 67 prescriptions per 1,000 women in the age group. The pharmacy data were aggregate counts: they can include refills for the same person and do not show how many individual women started or used therapy. The study was not designed to determine what caused the increase.
Dispensing rose for progesterone and for estrogen products used vaginally or through the skin, such as patches and gels. Oral formulations remained stable. The rise began before the US Food and Drug Administration’s November 2025 removal of a boxed warning from packaging and continued afterward.
The United States has also experienced a shortage of estrogen patches in 2026, which the FDA attributes to increasing demand.
Dana Sarnak, a sexual and reproductive health researcher at , offered possible explanations in

A study published November 17 also found that memory decline became less steep across successive generations, adding evidence about changes in memory as people age.
The Menopause Society has recommended hormone therapy for women with symptoms who are younger than 60 or within 10 years of the start of menopause, provided they do not have certain risk factors, including prior breast cancer or stroke.
2 min

Étienne Artigau’s team says the system, 28 light-years from Earth, is the nearest known triple-star system with two white dwarfs. The researchers are investigating how its red dwarf survived its companion’s expansion.
2 min

A radio signal received on 19 November showed the probe crossed the distance on 18 November at 10:16 GMT (14:16 Yerevan time), making it the first spacecraft to do so.
3 min